Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001246892 | SCV001420284 | pathogenic | Fanconi anemia | 2020-02-05 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant has been observed in an individual affected with Fanconi anemia (PMID: 25239263). This sequence change creates a premature translational stop signal (p.Ser852*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. |
Revvity Omics, |
RCV001780186 | SCV002022314 | pathogenic | Fanconi anemia complementation group A | 2019-05-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003117864 | SCV003798818 | pathogenic | not provided | 2022-08-05 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25239263) |
Baylor Genetics | RCV001780186 | SCV005057563 | pathogenic | Fanconi anemia complementation group A | 2024-02-09 | criteria provided, single submitter | clinical testing |